NOVAGALI PHARMA

No insider activity signals detected

Insider trades have not triggered unusual activity signals for this company.

Top insiders
Trades
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
EDMOND DE ROTHSCHILD INVESTMENT PARTNERS agissant pour le compte de fonds dont elle assure la gestion, Membre du Conseil de Surveillance Supervisory Board Member
Transaction date
Sale
Price
442.05
Quantity 85,858
Value €356,471
Kurma Life Sciences Partners agissant pour le compte de fonds dont elle assure la gestion, Membre du Conseil de Surveillance Supervisory Board Member
Through IdInvest Partners, a closely affiliated person
Transaction date
Sale
Price
308.70
Quantity 54,355
Value €3,170,778
Jérôme MARTINEZ Président du Directoire Management Board Member
Transaction date
Sale
Price
441.26
Quantity 71,200
Value €3,122,126
Alain MUNOZ Membre du Conseil de Surveillance Supervisory Board Member
Transaction date
Sale
Price
6.15
Quantity 27,248
Value €167,575
Bernard CHAUVIN Membre du Conseil de Surveillance Supervisory Board Member
Transaction date
Sale
Price
6.15
Quantity 344,917
Value €2,121,240
CDC INNOVATION agissant pour le compte de fonds dont elle assure la gestion, en qualité de Censeur du Conseil de Surveillance Supervisory Board Member
Transaction date
Sale
Price
6.15
Quantity 1,191,908
Value €7,330,234
AURIGA PARTNERS agissant pour le compte de fonds dont elle assure la gestion, Membre du Conseil de Surveillance Supervisory Board Member
Transaction date
Sale
Price
6.15
Quantity 2,229,784
Value €13,713,172
George LAZESKAY Membre du Conseil de Surveillance Supervisory Board Member
Transaction date
Sale
Price
6.15
Quantity 7,080
Value €43,542
Notification date Transaction date B/S Transaction type Insider and/or position Nb. shares
Price
Value
Number of shares Price Value Details
2011-10-20 2011-10-11 S Sale EDMOND DE ROTHSCHILD INVESTMENT PARTNERS

agissant pour le compte de fonds dont elle assure la gestion, Membre du Conseil de Surveillance

Supervisory Board Member
85,858
442.05
€356,471
85,858 442.05 €356,471
2011-10-20 2011-10-11 S Sale Kurma Life Sciences Partners

agissant pour le compte de fonds dont elle assure la gestion, Membre du Conseil de Surveillance

Through IdInvest Partners, a closely affiliated person Supervisory Board Member
54,355
308.70
€3,170,778
54,355 308.70 €3,170,778
2011-10-20 2011-10-11 S Sale

Président du Directoire

Management Board Member
71,200
441.26
€3,122,126
71,200 441.26 €3,122,126
2011-10-20 2011-10-11 S Sale

Membre du Conseil de Surveillance

Supervisory Board Member
27,248
6.15
€167,575
27,248 6.15 €167,575
2011-10-20 2011-10-11 S Sale

Membre du Conseil de Surveillance

Supervisory Board Member
344,917
6.15
€2,121,240
344,917 6.15 €2,121,240
2011-10-20 2011-10-11 S Sale CDC INNOVATION

agissant pour le compte de fonds dont elle assure la gestion, en qualité de Censeur du Conseil de Surveillance

Supervisory Board Member
1,191,908
6.15
€7,330,234
1,191,908 6.15 €7,330,234
2011-10-20 2011-10-11 S Sale AURIGA PARTNERS

agissant pour le compte de fonds dont elle assure la gestion, Membre du Conseil de Surveillance

Supervisory Board Member
2,229,784
6.15
€13,713,172
2,229,784 6.15 €13,713,172
2011-10-20 2011-10-11 S Sale

Membre du Conseil de Surveillance

Supervisory Board Member
7,080
6.15
€43,542
7,080 6.15 €43,542
Explore more

More insider trading research around NOVAGALI PHARMA